The dialysis-services company lost less money than it expected and issued a favorable outlook for the full year. NxStage Medical's third-quarter results continued the company's trends toward ...

NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

The pending acquisition by Fresenius put NxStage's second-quarter financial report in a much different context. Coming into Monday's second-quarter financial report, NxStage investors had no inkling ...

NxStage Medical, Inc. NXTM recently announced that its subsidiary NxStage Kidney Care is partnering Dialyze Direct for supporting the needs of patients who need on-site skilled-nursing facilities (SNF ...

NxStage Medical (NASDAQ: NXTM) has been in limbo since mid-2017, when it received an offer from Fresenius Medical Care (NYSE: FMS) to buy the company. Since then, shares of NxStage have stayed ...

While the strategic rationale behind Fresenius Medical Care's $2 billion bid for NxStage Medical is clear, the timing of the deal is vague. Amanda Pedersen As Fresenius Medical Care kicked off a ...

NxStage Medical, Inc.NXTM announced that its Nx2me Connected Health (remote patient management system) reduces home hemodialysis technique failure or conversion to in-center hemodialysis by 29%.

Dialysis product manufacturer NxStage Medical Inc. has created a dosing calculator Designed for use with the NxStage System One to help physicians develop prescriptions tailored to patients' clinical ...

Missing dialysis treatments can be a matter of life and death for patients with end-stage renal disease (ESRD). However, the portability of the System One allows home patients to take their machines ...

Home-dialysis specialist NxStage Medical (NASDAQ: NXTM) has worked hard toward making a profit, but it also hasn't hesitated to spend money in an effort to promote faster growth in the future. Coming ...